AI-Driven Imaging Biomarkers : imaging biomarkers



Image Analysis Group and Picture Health have formed a strategic partnership to integrate artificial intelligence-driven imaging biomarkers into oncology clinical trials. Through this approach, the collaborators aim to enhance the precision and efficiency of cancer treatment development.

The strategic partnership brings together Image Analysis Group’s established clinical trial imaging expertise and its DYNAMIKA™ platform with Picture Health’s advanced AI technology, which extracts predictive insights from standard medical scans using radiomics and pathomics. The combined capabilities are designed to provide pharmaceutical companies and researchers with improved tools for detecting early treatment responses, optimizing patient selection, and forecasting therapeutic outcomes more accurately.

By automating data analysis and enabling biologically interpretable imaging biomarkers, the partnership seeks to reduce trial timelines and investment risks while maintaining regulatory compliance.

Image Credit: Image Analysis Group and Picture Health



Source link

Highly Detailed Anime Figurines : Guyver II

What Makes a Good Shoe? Fit and Quality Explained

Leave a Reply

Your email address will not be published. Required fields are marked *